Phase II Study of a Geriatric Vulnerability Based, Personalized Allogeneic Hematopoietic Transplantation Strategy for Older, Vulnerable Patients with Myelodysplastic Syndrome.
Memorial Sloan-Kettering Cancer Center was awarded a $250,000 grant over two years to support early career investigator Dr. Richard J. Lin.
Dr. Lin will conduct this research with the support of his mentor
Dr. Sergio A. Giralt to evaluate the efficacy of an adapted strategy based on geriatric vulnerabilities and geriatric management to reduce non-relapse mortality for older MDS patients receiving curative intent allogeneic hematopoietic transplantation.
Learn more about Memorial Sloan-Kettering Cancer Center